Abstract Background: Cannabidiol (CBD), the major non-psychotropic cannabinoid derived from Cannabis sativa L., has demonstrated broad anticancer activity across multiple…
Abstract Objective: This study aimed to investigate the blood serum levels of biomarkers specifying oxidative stress status and systemic inflammation…
Abstract Cannabidiol (CBD) exhibits anti-inflammatory, anxiolytic, antiseizure, and neuroprotective proprieties without addictive or psychotropic side effects, as opposed to Δ9-tetrahydrocannabinol…
Abstract Cannabidiol is a novel antiseizure medication approved in Europe and the US for the treatment of seizures associated with…
Abstract Long-term cannabis use during adolescence has deleterious effects in brain that are largely ascribed to the activation of cannabinoid-1…
Abstract Objective: Cannabinoids are able to reduce tumor growth in xenograft models, but their therapeutic potential as anti-cancer drugs in…
Abstract Earlier this year we published a method article aimed at optimising protein extraction from mature buds of medicinal cannabis…
Keywords: BSA, bovine serum albumin, DCC, DIBAH, diisobutylaluminium hydride, DMF, ELISA, enzyme-linked immunosorbent assay, GAR, goat anti-rabbit antibody, GAR-Po, peroxidase…